Off-the-shelf cema-cel clears MRD at more than triple the rate of observation alone—and may propel a shift to frontline use of CAR T-cell therapy when relapse is hard to detect. For years, the promise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results